, Adult lymphoblastic lymphoma Hoelzer D, G ¨ okbuget N: Treatment of lymphoblastic lymphoma in adults, Cancer J Best Pract Res Clin Haematol, vol.18, issue.15, pp.432-438713, 2002.
, Treatment of lymphoblastic lymphoma in adults Lymphoblastic lymphoma, Oncology Crit Rev Oncol Hematol, vol.23, issue.79, pp.1015-1020330, 2011.
, Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials, Leukemia, vol.17, issue.11, pp.2220-2224, 2003.
DOI : 10.1038/sj.leu.2403095
, Pediatric-Like Therapy for Adults with ALL, Current Hematologic Malignancy Reports, vol.118, issue.11, pp.158-164, 2014.
DOI : 10.1007/s11899-014-0210-9
, Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome???Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study, Journal of Clinical Oncology, vol.27, issue.6, pp.911-918937, 2009.
DOI : 10.1200/JCO.2008.18.6916
, Report of the Committee on Hodgkin's Disease Staging Classification, Cancer Res, vol.31, pp.1860-1861, 1971.
, NOTCH1/ FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): A Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study Toward a NOTCH1/FBXW7/RAS/PTEN- based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia study Clinical impact of NOTCH1 and/or FBXW7 mutations, FLASH deletion, and TCR status in pediatric T-cell lymphoblastic lymphoma, Blood J Clin Oncol J Clin Oncol, vol.113, issue.30, pp.3918-39244333, 2009.
, Proposals for the immunological classification of acute leukemias Toxicity and response criteria of the Eastern Cooperative Oncology Group NCI Sponsored International Working Group: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas Absence of biallelic TCRg deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma, European Group for the Immunological Characterization of Leukemias (EGIL) al: Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma, pp.1783-1786649, 2002.
, Serum lactic dehydrogenase level has prognostic value in childhood acute lymphoblastic leukemia Prognosis and treatment of lymphoblastic lymphoma in adults: A report on 80 patients, Blood J Clin Oncol, vol.66, issue.10, pp.778-7821078, 1992.
, Comparison of HyperCVAD regimen and CHOP regimen in treating patients with lymphoblastic lymphoma
, Treatment outcome in T-cell lymphoblastic lymphoma in adults: A population-based study from the Swedish Lymphoma Registry Superior vena cava syndrome and poor performance status at presentation affect survival in mediastinal Tlymphoblastic lymphoma?a single institute experience from India A clinicopathological study of 96 cases of lymphoblastic lymphoma [in Chinese] Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL): Oncogenetics and minimal residual disease are independent outcome predictors in adult patients with acute lymphoblastic leukemia Absence of biallelic TCRg deletion predicts induction failure and poorer outcomes in childhood T-cell acute lymphoblastic leukemia Lymphoma Study Writing Committee, International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry: A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/ maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: Results of a randomized trial of the European Group for Blood and Marrow Transplantation and the United Kingdom Lymphoma Group The role of FDG-PET scans in patients with lymphoma, 33. G ¨ okbuget N, Wolf A, Stelljes M, et al: Favorable outcome in a large cohort of prospectively treated adult patients with T-lymphoblastic lymphoma (T-LBL) despite slowly evolving complete remission assessed by conventional radiography. Presented at the 56th Annual ASH Annual Meeting and Exposition, pp.1441-1450927, 2001.
, Institut Necker-Enfants Malades, INSERM U1151, and Assistance Publique-H ? opitaux de Paris, Hôpital Necker Enfants-Malades; Emmanuel Raffoux and Hervé Dombret, Hôpital Saint-Louis Diderot; JosetteBrì ere, Hôpital Saint-Louis, Maladies du sang CHU Angers JOURNAL OF CLINICAL ONCOLOGY Lepretre et al Downloaded from ascopubs.org by INSERM on, p.54033, 2016.
, Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www
, Expenses: Genentech Thierry Lamy No relationship to disclose Marie-Christine Béné Research Funding: Beckman Coulter Emmanuel Raffoux No relationship to disclose Françoise Huguet No relationship to disclose Patrice Chevallier No relationship to disclose Serge Bologna No relationship to disclose Réda Bouabdallah No relationship to disclose Jacques Benichou No relationship to disclose JosetteBrì ere No relationship to disclose Anne Moreau No relationship to disclose Valérie Tallon-Simon No relationship to disclose Stephanie Seris No relationship to disclose Carlos Graux No relationship to disclose Vahid Asnafi No relationship to disclose Norbert Ifrah No relationship to disclose Elizabeth Macintyre Patents, Royalties, Other Intellectual Property: Participate in royalty sharing agreement Hervé Dombret Research Funding: Roche www.jco.org